NAD, whose full name is nicotinamide adenine dinucleotide, is a coenzyme found in all living cells. It plays a pivotal role in various biological processes, including energy metabolism, DNA repair, and cell signaling. Over the past few decades, researchers have been intensively studying the relationship between NAD and cancer, aiming to understand how NAD levels and its related metabolic pathways influence the development, progression, and treatment of cancer. As a reliable NAD supplier, we are committed to providing high - quality NAD products that meet the demands of scientific research and potential therapeutic applications in the field of cancer.
The Role of NAD in Normal Cellular Processes
Before delving into the relationship between NAD and cancer, it is essential to understand its functions in normal cells. NAD exists in two forms: oxidized form (NAD+) and reduced form (NADH). These two forms interconvert during enzymatic reactions and participate in redox reactions within cells.
In the mitochondria, NAD+ is a crucial component of the electron transport chain, which is responsible for generating ATP through oxidative phosphorylation. During glycolysis and the citric acid cycle, NAD+ accepts electrons and protons to form NADH. Subsequently, NADH donates its electrons to the electron transport chain, leading to the production of ATP, the energy currency of the cell.
NAD+ is also involved in non - redox reactions. For example, it serves as a substrate for enzymes such as sirtuins and poly(ADP - ribose) polymerases (PARPs). Sirtuins are a family of proteins that regulate various cellular processes, including DNA repair, gene expression, and aging. They require NAD+ to remove acetyl groups from target proteins, thereby modulating their activity. PARPs, on the other hand, are involved in DNA repair. When DNA is damaged, PARPs are activated and use NAD+ to synthesize poly(ADP - ribose) chains on target proteins, which helps recruit other DNA repair proteins to the damaged site.
NAD and Cancer Metabolism
Cancer cells have unique metabolic characteristics compared to normal cells. They often rely on aerobic glycolysis, also known as the Warburg effect, to generate energy even in the presence of oxygen. This metabolic shift allows cancer cells to rapidly produce ATP and obtain the building blocks necessary for cell growth and proliferation.
NAD+ is closely related to cancer cell metabolism. In the process of aerobic glycolysis, glyceraldehyde - 3 - phosphate dehydrogenase (GAPDH) uses NAD+ to convert glyceraldehyde - 3 - phosphate to 1,3 - bisphosphoglycerate. Therefore, maintaining a sufficient supply of NAD+ is crucial for cancer cells to carry out glycolysis. Some studies have shown that cancer cells upregulate the expression of enzymes involved in NAD+ synthesis, such as nicotinamide phosphoribosyltransferase (NAMPT), to ensure an adequate NAD+ level for their high - energy demands.
Moreover, the redox balance between NAD+ and NADH is also important for cancer cells. An imbalance in this ratio can lead to oxidative stress, which may damage cellular components and affect cell survival. Cancer cells have developed various mechanisms to maintain the appropriate redox balance, and NAD+ - related metabolic pathways play a key role in this process.
NAD - Dependent Enzymes and Cancer
As mentioned earlier, sirtuins and PARPs are NAD - dependent enzymes that are closely related to cancer.
Sirtuins
Sirtuins have been shown to have both tumor - suppressive and tumor - promoting effects, depending on the specific sirtuin isoform and the cellular context. For example, SIRT1 is involved in regulating the activity of p53, a well - known tumor suppressor protein. SIRT1 can deacetylate p53, leading to its inactivation. In some cases, high levels of SIRT1 may promote tumor growth by inhibiting the tumor - suppressing function of p53. However, SIRT6, another sirtuin isoform, has been reported to have tumor - suppressive properties. SIRT6 can regulate DNA repair and telomere maintenance, and its downregulation is associated with increased tumorigenesis.
PARPs
PARPs are essential for DNA repair, especially for the repair of single - strand breaks. Inhibition of PARP enzymes has emerged as a promising strategy for cancer treatment, particularly in cancers with defects in homologous recombination repair, such as BRCA1/2 - mutated breast and ovarian cancers. When PARP is inhibited, the repair of single - strand breaks is impaired, leading to the accumulation of DNA damage. In cells with defective homologous recombination, this can result in the formation of double - strand breaks and ultimately cell death through synthetic lethality. PARP inhibitors require a sufficient level of NAD+ as a substrate for the formation of poly(ADP - ribose) chains, and the availability of NAD+ may affect the efficacy of PARP inhibitors.
NAD Levels and Cancer Progression
Several studies have investigated the changes in NAD levels during cancer progression. In general, NAD+ levels tend to be altered in cancer cells compared to normal cells. Some cancers show an upregulation of NAD+ synthesis pathways, while others may have a decrease in NAD+ levels due to increased consumption or impaired synthesis.
The change in NAD+ levels can have a significant impact on cancer cell behavior. For example, a decrease in NAD+ levels may lead to a reduction in ATP production, which can inhibit cancer cell growth and proliferation. On the other hand, an increase in NAD+ levels may support the high - energy demands of cancer cells and promote their survival and metastasis.


Moreover, the relationship between NAD+ levels and the tumor microenvironment is also an area of active research. The tumor microenvironment consists of cancer cells, stromal cells, immune cells, and the extracellular matrix. NAD+ can be released from cells and act as a signaling molecule in the extracellular space. It can affect the function of immune cells, such as macrophages and T cells, which play important roles in anti - tumor immunity. Therefore, modulating NAD+ levels in the tumor microenvironment may have potential therapeutic implications for cancer treatment.
Potential Therapeutic Strategies Targeting NAD
Based on the understanding of the relationship between NAD and cancer, several therapeutic strategies have been proposed.
NAD+ Precursors
Supplementation of NAD+ precursors, such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), has been suggested as a way to increase intracellular NAD+ levels. In pre - clinical studies, increasing NAD+ levels through precursor supplementation has been shown to enhance the activity of NAD - dependent enzymes, such as sirtuins and PARPs, and may have potential anti - cancer effects. However, the effect of NAD+ precursor supplementation on cancer treatment needs to be further explored, as the impact on cancer cells and normal cells may be different.
Inhibitors of NAD Synthesis Enzymes
Inhibiting the enzymes involved in NAD+ synthesis, such as NAMPT, is another therapeutic strategy. By blocking NAD+ synthesis, it may be possible to deprive cancer cells of the necessary NAD+ for their survival and proliferation. Several NAMPT inhibitors have been developed and are currently being investigated in clinical trials. However, the potential side effects of these inhibitors on normal cells need to be carefully evaluated, as normal cells also require NAD+ for their normal functions.
Our Role as an NAD Supplier
As a leading NAD supplier, we are dedicated to supporting the research and development in the field of cancer and NAD. Our high - quality NAD products are produced under strict quality control standards, ensuring their purity and stability. We understand the importance of reliable reagents in scientific research, and our products have been widely used in various laboratories around the world.
Whether you are conducting basic research on the relationship between NAD and cancer metabolism or exploring novel therapeutic strategies targeting NAD, our products can provide the necessary support. We also offer technical support and customized solutions to meet your specific research needs.
If you are interested in our NAD products or have any questions regarding their applications in cancer research, please feel free to contact us for procurement and further discussions. We look forward to collaborating with you to advance the understanding and treatment of cancer.
In addition, we would like to introduce some related products on our website. You can find more information about the CAS NO. 87 - 51 - 4 Premium Plant Growth Regulator Iaa Indole - 3 - Acetic Acid 98%Tc, CAS 87 - 51 - 4 Iaa Indole - 3 - Acetic Acid 98 Tc Agricultural Plant Growth Promotion, and Agricultural Growth Regulator Powder Iba Indole - 3 - Butyric Acid 98%Tc C12H13NO2 CAS 133 - 32 - 4.
References
- Canto C, Houtkooper RH, Pirinen E, et al. The NAD(+) metabolome and the control of energy homeostasis: signaling, metabolism, and Therapeutics. Cell Metab. 2015;22(2):113 - 128.
- Luo J, Nikolaev AY, Imai S, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107(2):137 - 148.
- Bryant HE, Schultz N, Thomas HD, et al. Specific killing of BRCA2 - defective tumors with inhibitors of poly(ADP - ribose) polymerase. Nature. 2005;434(7035):913 - 917.
- Zhang Y, Kraus WL. The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets. Mol Cell. 2010;39(1):8 - 24.



